Today: 11 June 2026
Marvell stock ends week with an 8% jump as chip rally returns — but a new share-sale filing hangs over Monday
8 February 2026
1 min read

Marvell stock ends week with an 8% jump as chip rally returns — but a new share-sale filing hangs over Monday

NEW YORK, Feb 7, 2026, 19:49 EST — The market has closed.

Marvell Technology Inc (MRVL) finished Friday’s session up 8.18% at $80.28 as chip stocks rallied. After hours, the last trade crossed at $81.51.

That jump is in focus as the U.S. session kicks off Monday, following a shaky patch for parts of big tech that’s put a familiar debate back on the table: Is all this AI spending still boosting hardware stocks, or is it starting to weigh them down? “Rotation is the dominant theme this year,” said Angelo Kourkafas, senior global investment strategist at Edward Jones, noting that investors are pulling cash from trades that have gotten too crowded. Reuters

Wall Street piled back into semis on Friday, betting that Big Tech is still spending on data centers. Amazon now expects capital expenditures to surge over 50% this year, echoing Alphabet’s recently announced ramp-up. Nvidia tacked on 7.8%, AMD ran up 8.3%, and Broadcom finished 7.1% higher, with the Philadelphia semiconductor index notching a 5.7% gain. “There’s real demand for AI products,” Baird investment strategy analyst Ross Mayfield said. Reuters

Late Friday, Marvell handed investors a new prospectus supplement, registering up to 24,222,758 shares for potential resale by “selling securityholders.” The stock was originally issued to complete its Celestial AI acquisition, which closed Feb. 2, according to the filing. Marvell won’t see any proceeds from these sales. The company also cited the Nasdaq closing price of $74.21 from Feb. 5. Marvell Technology, Inc.

Marvell, in its latest 8-K, said it filed the report to provide a legal opinion from Wilson Sonsini Goodrich & Rosati about the issuance and sale of securities listed in the prospectus supplement. Chief Legal Officer Mark Casper signed the filing.

The resale registration is a double-edged sword. If holders decide to sell, more shares could hit the market. This comes as investors are still hashing out who benefits from the AI push, with rising spending and debt adding to the mix.

Investors continue to circle back to the usual narrative: AI data centers remain the engine behind chip demand. Still, there’s a sense the market doesn’t want to front-run the actual cycle. The Semiconductor Industry Association projects global chip sales climbing to $1 trillion in 2026, following $791.7 billion in 2025. SIA chief John Neuffer told Reuters, “My orders are completely full.” Reuters

There’s a good chance macro takes center stage next week. U.S. January CPI lands Feb. 13 at 8:30 a.m. ET; that release can jolt rate-cut bets and whip valuations for growth names that hinge on future earnings.

Marvell’s immediate focus comes down to two things: Will Monday’s open on Feb. 9 carry forward Friday’s chip rally, and do traders turn their attention to possible pressure from fresh resale stock registrations once this week’s data drops?

Stock Market Today

  • What is an IPO as SpaceX Prepares for U.S. Stock Market Debut
    June 10, 2026, 6:01 PM EDT. An IPO, or Initial Public Offering, is when a private company sells shares to the public for the first time, becoming publicly traded. SpaceX, the aerospace manufacturer, is expected to make its debut on the U.S. stock market, marking one of the most anticipated IPOs in recent years. This move allows retail and institutional investors to buy equity in SpaceX, potentially impacting the space industry and tech sectors. The IPO process involves regulatory filings, pricing, and public trading, providing companies with capital for expansion. SpaceX's offering could reshape market dynamics, drawing significant investor interest given its innovations and growth trajectory.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Deutsche Telekom stock slips despite fresh buyback — what matters before earnings
Previous Story

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

Fortescue share price set for Monday test as Cyclone Mitchell shuts Port Hedland
Next Story

Fortescue share price set for Monday test as Cyclone Mitchell shuts Port Hedland

Go toTop